RedHawk Holdings Corp. Announces Consolidated Earnings Results for the Third Quarter Ended March 31, 2017

Redhawk Holdings Corp. is a diversified holding company. The Company, through its subsidiaries, is engaged in sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investments and leasing, sales of point of entry full-body security system, and specialized financial services. The Company’s segments include Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. Land & Hospitality and Other Services segment operates in the United States. Medical Device and Pharmaceutical segment operate primarily in the United Kingdom. Its land and hospitality business unit consists of commercial and residential property under a long-term lease. It is engaged in commercial restoration project Grand Naniloa Hotel, in Hawaii. Its medical device and pharmaceutical business unit is engaged in manufacture and sale of Sharps and Needle Destruction Devices and Carotid Artery Digital Non-Contact Thermometer.